期刊论文859-P: ALN-KHK, an Investigational RNA Interference Therapeutic, Successfully Targets Hepatic Ketohexokinase in a Single Ascending Dose Study of Overweight to Obese Adults复制

DOI: 10.2337/db24-859-P复制

文献链接: https://diabetesjournals.org/diabetes/article/73/Supplement_1/859-P/156520/859-P-ALN-KHK-an-Investigational-RNA-Interference复制

其他信息:

出版社: American Diabetes Association
作者: ELEFTHERIA MARATOS-FLIER; TIRTHA NANDI; KATHERINE BOYLE; XINGYU LI; YUANFENG WU; LEILA NOETZLI; FARSHAD KAJBAF; GAETANO MORELLI
全文下载地址: https://diabetesjournals.org/diabetes/article/73/Supplement_1/859-P/156520/859-P-ALN-KHK-an-Investigational-RNA-Interference